Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial - Ferris, R L; Spanos, W C; Leidner, R (J Immunother Cancer, 2021)